CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

August 23, 2018

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Invasive Pneumococcal Disease, Protection AgainstStreptococcus Pneumoniae Infection
Interventions
BIOLOGICAL

PCV13

Vaccine against pneumococcal disease

Trial Locations (1)

V5Z 4H4

Vaccine Evaluation Center (University of BC at Children's Hospital), Vancouver

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Immunization Research Network

NETWORK

collaborator

Alberta Children's Hospital

OTHER

collaborator

Université de Montréal

OTHER

collaborator

IWK Health Centre

OTHER

collaborator

University of Calgary

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of British Columbia

OTHER